Buy Score Rank #4013 out of #5176
Wed 26'th Jul 2017
Aethlon Medical Stock Analysis
Technical stock analysis for Wed 26'th Jul 2017
Sell candidate since 2017-07-07 Loss -1.91%
Aethlon Medical lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -4.41% during the next 3 months and, with 90% probability hold a price between $1.48 and $2.25 at the end of this period.
Aethlon Medical holds buy signals from both short- and long-term moving averages, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down there will be some support from the lines at $1.99 and $2.04. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday July 25, 2017, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.
Relative Strength Index (RSI)
RSI14 is 53 and the stock is currently not being overbought or oversold
Support & Resistance
Aethlon Medical finds support from accumulated volume at . On the upside the stock meets some resistance from accumulated volume at $2.26, $2.40 and $2.33.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.16 between high and low, or 8.12%. For the last week the stock has had a daily average volatility of 7.14%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Aethlon Medical holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our recommendation for this stock since last evaluation from a Strong Sell Candidate to a Sell Candidate.